About Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT

The Irish Cancer Society‘s first Collaborative Cancer Research Centre is called BREAST-PREDICT.

A strong team of expert Irish researchers, including most of Ireland’s leading names in breast cancer research, will collect and study information such as tumour samples from practically every breast cancer patient in the country in a five-year unique state-of-the-art study to determine how best to treat individual breast cancer patients, according to the particular characteristics of their own cancer.

The research team will examine the changes that take place in this disease which determine, for instance, whether patients respond to a particular drug, how their cancers change over time while they are being treated and whether drugs that they may have been taking prior to their diagnosis have any effect on the outcome of their cancer treatment.

The Centre will also test ways to find new treatment strategies, either by using existing drugs for the correct patient or by identifying new combinations of drugs that will help patients to beat their disease more effectively. It will also develop new tools for improved prediction of patient outcome and response to treatment.

Six academic centres

Involving six leading academic centres around Ireland with expert computational and laboratory scientists, as well as a nationwide cancer-focused clinical trials group, the Irish Cancer Society’s first Collaborative Cancer Research Centre BREAST-PREDICT is a truly country-wide effort to improve the lives of Irish breast cancer patients.

The promise of this new collaborative centre has already energised the Irish and European cancer community. We hope you will be inspired to find out more about how you too can help the Irish Cancer Society take this vital step in our journey towards a future without cancer.

To find out more about Collaborative Cancer Research Centre BREAST-PREDICT, please see www.breastpredict.com